When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies
S. Olson +5 more
semanticscholar +1 more source
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. [PDF]
Ahmad +65 more
core +1 more source
Convalescent Plasma for Ebola Virus Disease [PDF]
Fischer, William +2 more
core +5 more sources
The Interaction Between Coagulation and Complement Cascades in the Management of Thrombotic Microangiopathies Related to Postpartum Hemorrhage. [PDF]
Orsi M, Ossola MW, Cetin I, Ardissino G.
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran +28 more
core +1 more source
Eculizumab in Acute Recurrence of Thrombotic Microangiopathy After Renal Transplantation [PDF]
Karine Hadaya +7 more
openalex +1 more source
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.
F. Bu +15 more
semanticscholar +1 more source
Thrombotic microangiopathy during peripheral blood stem cell mobilization [PDF]
Harris Naina +2 more
openalex +1 more source
P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis [PDF]
Aliisa Häyry +4 more
openalex +1 more source

